An exploratory trial of Oxtellar XR in patients with bipolar disorder
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2018
Price : $35 *
At a glance
- Drugs Oxcarbazepine (Primary) ; Oxcarbazepine
- Indications Bipolar disorders
- Focus Adverse reactions; Therapeutic Use
- 27 Feb 2018 According to a Supernus media release, enrollment in this trial is expected to complete by year end 2018.
- 06 Nov 2017 According to a Supernus media release, status changed from planning to recruiting.
- 10 Mar 2017 New trial record